Aspirin
Brand Names: Drug Mart Effervescent Pain Relief, Wispirin, Medline, Ecotrin, Bayer Low Dose, Equaline Effervescent Pain Reliever
Methodology & AI Transparency ⓘ
Aspirin Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Federal monograph 198467 classifies Aspirin as a nonprescription nonsteroidal anti-inflammatory drug (325 mg/1 Tablet, Film Coated): temporarily relieves: headache - pain and fever of colds - toothache - menstrual pain - muscle pain - minor pain of arthritis
- 2 Real-world patient consensus: Real-world cohort score of 82% across 20 de-identified Aspirin entries.
- 3 Typical cash cost range: 30-day cash pricing ranges from $5.98 on Cost Plus Drugs to $34.50 walk-in retail (NADAC $0.0253/unit).
- 4 Top reported side effects / signs: Primary clinical safety signals tracked in FAERS for Aspirin include headache (9.9%), abdominal discomfort (4.1%), myalgia (6.2%).
Ask our AI Specialists anything about Aspirin
Aspirin Mechanism, CYP450 Pathways & DailyMed Monograph
Federal monograph 198467 classifies Aspirin as a nonprescription nonsteroidal anti-inflammatory drug (325 mg/1 Tablet, Film Coated): temporarily relieves: headache - pain and fever of colds - toothache - menstrual pain - muscle pain - minor pain of arthritis
As an active nonsteroidal anti-inflammatory drug moiety (HF Acquisition Co LLC, DBA HealthFirst), Aspirin modulates physiological signaling proportional to 325 mg/1 Tablet, Film Coated exposure and hepatorenal clearance (SPL 2025-05-01).
Clinical clearance of Aspirin (Nonsteroidal Anti-inflammatory Drug) relies on systemic clearance of aspirin integrates hepatic phase ii conjugation with renal filtration with a Elimination kinetics span 8 to 20 hours per Aspirin clinical pharmacology half-life; patients absorbing at Consistent 60%–72% gastrointestinal absorption profile for Aspirin bioavailability typically observe target onset around cmax attained 2–5 hours post-administration of aspirin.
FDA clinical labeling for Aspirin restricts administration in previous anaphylactoid or exfoliative reaction attributed to aspirin; clinical scenarios where nonsteroidal anti-inflammatory drug exposure from aspirin poses unacceptable risk across 325 mg/1 Tablet, Film Coated, 81 mg/1 Tablet, Coated, 81 mg/1 Tablet, Delayed Release, 81 mg/1 Tablet, Chewable, 81 mg/1 Tablet, with self-reported patient tracking dominated by headache (9.9% of reports), nausea (8.6% of reports), myalgia (6.2% of reports).
Verify medication reconciliation lists so Aspirin is not inadvertently duplicated with another nonsteroidal anti-inflammatory drug.
Alcohol or high-fat meal timing can shift absorption rate and orthostatic tolerance during Aspirin dosing.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Previous anaphylactoid or exfoliative reaction attributed to Aspirin
- Clinical scenarios where nonsteroidal anti-inflammatory drug exposure from Aspirin poses unacceptable risk
Logged Side-Effect Incidence (20 Reports)
Aspirin Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Aspirin)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Fixed dose combination of aspirin and pantoprazole: Results of a multicenter,: What a 240-Participant Study Found The fixed-dose combination of aspirin 150 mg and pantoprazole 20 mg was found to be more efficacious and safer compared to aspirin 150 mg alone for the prevention of gastroduodenal mucosal damage in patients receiving aspirin. Indian heart journal • 2024-01-15 • Phase III Randomized Trial | N = 240 | 88/100 | PMID 39009075 ↗ |
| New Insights on Aspirin dose, urinary thromboxane and prostacyclin metabolites, and clinical: What a 275-Participant Study Found In acute coronary syndrome, higher-dose aspirin modestly reduced urinary thromboxane without lowering the urinary prostacyclin metabolite. Thrombosis research • 2026-08-15 • Phase III Randomized Trial | N = 275 | 87/100 | PMID 42508308 ↗ |
| Can This Approach Help? Inside the Latest Research on Early Neurologic Deterioration and Efficacy of Dual Antiplatelet in Anterior Our study demonstrated END was higher in acute mild-to-moderate ischemic stroke with anterior circulation, who derived more benefit from clopidogrel plus aspirin than aspirin alone. Journal of the American Heart Association • 2025-02-04 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 39846303 ↗ |
Aspirin Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0253/unit (~$0.76/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $5.98 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 20 Anonymous DotMD Community Micro-Logs | $7.50 / mo | View logs ↓ |
Aspirin Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Aspirin RxNorm Concept ID | 198467 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0253 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $5.98 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 82.00% Worth It (20 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Aspirin Patient Community, Cohort Filters & Dosage Logs
Evidence synthesis for Aspirin: FDA labeling (2025-05-01, NDC 50804-157), CYP/interaction screening, and public pharmacy acquisition costs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Aspirin community threads and patient logs by age, biological sex, dosage, and treatment duration.